NASDAQ: OKYO
Okyo Pharma Ltd Earnings Dates, Reports, Calls

Okyo Pharma earnings were -$10.7M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest OKYO earnings report on Sep 30, 2024 announced Q3 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, OKYO reported annual earnings of -$16.8M, with 26.8% growth.

OKYO earnings history

Current Revenue
$0.0
Current Earnings
-$10.7M
Current Profit Margin
0%

OKYO Return on Equity

Current Company
N/A
Current Industry
19.9%
Current Market
35%

OKYO undefined

Current Company
-410.6%
Current Industry
1.3%

Be the first to know when OKYO announces earnings.

OKYO undefined

Current Company
143.3%
Current Industry
14.3%
OKYO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OKYO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OKYO-$10.35M-$10.69MN/A-$0.38
ANEB-$7.43M-$7.67MN/A-$0.28
HOWL-$63.16M-$70.52MN/A-$1.63
KPTI-$38.60M-$76.42MN/A-$9.45
CNTB-$14.75M-$15.63MN/A-$0.28

Okyo Pharma Earnings Reports & History FAQ

What were Okyo Pharma's earnings last quarter?

On OKYO's earnings call on Invalid Date, Okyo Pharma (NASDAQ: OKYO) reported Q3 2024 earnings per share (EPS) of N/A, up N/A year over year. Total OKYO earnings for the quarter were N/A. In the same quarter last year, Okyo Pharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Okyo Pharma stock.

Is Okyo Pharma profitable or losing money?

As of the last Okyo Pharma earnings report, Okyo Pharma is currently losing money. Okyo Pharma's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$10.69 million, a 35.4% decrease year over year.

What was OKYO's earnings growth in the past year?

As of Okyo Pharma's earnings date in Invalid Date, Okyo Pharma's earnings has grown year over year. OKYO earnings in the past year totalled -$10.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.